The Hospital for Sick Children
Tamorah Lewis MD, PhD is a physician-scientist at Children’s Mercy Hospital in Kansas City, MO. She is dual trained in neonatal/perinatal medicine and clinical pharmacology. Her research program focuses on developmental pharmacology and pharmacogenetics in the neonatal population. As an Associate Professor in the Department of Pediatrics at The University of Missouri, Kansas City School of Medicine, she practices clinical neonatology and works collaboratively to design, implement, and manage her clinical and translational research program in Neonatal Precision Therapeutics. The overarching goal of her research program is to bring individualized medicine to the NICU population using modern pharmacology tools. Her research career will focus on elucidating the pharmacokinetics, pharmacodynamics and pharmacogenetics of both old and new drugs used to treat neonatal disease, with an emphasis on optimizing and individualizing drug therapy in neonates.
Dr Lewis serves as the Director of Clinical Research Logistics for her Division. She has established the Maternal Neonatal Pharmacogenetic Repository at Children’s Mercy Hospital and has multiple prospective pharmacogenetic cohort studies enrolling and depositing diverse bio-samples to this repository. In addition, she has established research collaborations at UCSF (steroid pharmacogenetics), Vanderbilt (ductus arteriosus pharmacogenetics), and Univ of Buffalo (NSAID PK) and is actively engaged as site PI in multi-site studies assessing neonatal drug safety and efficacy.
Dr Lewis is actively engaged in research societies. She sits on the Board of Directors for the American Society of Clinical Pharmacology and Therapeutics and is on the Executive Committee of the American Academy of Pediatrics (AAP) Section on Clinical Pharmacology and Therapeutics. Dr Lewis is also a member of the International Neonatal Consortium, a multi-stakeholder collaboration run by the Critical Path Institute to advance neonatal therapeutics.
Disclosure information not submitted.
Thursday, January 13, 2022
4:15 PM – 5:15 PM ET
Wednesday, March 16, 2022
12:00 PM – 1:00 PM ET
Friday, March 18, 2022
12:23 PM – 12:27 PM ET
.png)